Diabetic patients run three times the risk of developing liver cancer

Diabetic patients run three times the risk of developing liver cancer, suggests a large US study in Gut.

The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.

They found 2061 patients with liver cancer on records spanning the five years between 1994 and 1999. They also randomly selected more than 6,000 other similarly aged patients from the database, who had not been diagnosed with cancer.

They checked the claims records for known risk factors for liver cancer, including hepatitis C and B viral infections, alcoholic liver disease, and haemochromatosis (poor absorption and storage of iron). They also checked the claims records for diabetes.

Compared with patients who did not have the disease, those with liver cancer were around twice as likely to be male and of non-white ethnicity. And the proportion of patients with diabetes was almost twice as high among those with liver cancer.

After taking into account, demographics and other major risk factors, diabetes almost tripled the risk of liver cancer. But the findings also suggest that hepatitis C could also interact with diabetes to further boost the risk of developing liver cancer.

The authors suggest that diabetes might be an independent risk factor for liver cancer, rates of which have increased significantly in the US in recent years.

Contact: Dr Hashem El-Serag, Houston Veteran Affairs Medical Center, Houston, Texas, USA Tel: +1 713 794 8614 Email: [email protected]

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine shows potential in preventing recurrence of triple-negative breast cancer